These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1554877)

  • 21. Dose-dependent changes in sulfamethazine kinetics in rapid and slow isoniazid acetylators.
    Olson W; Miceli J; Weber W
    Clin Pharmacol Ther; 1978 Feb; 23(2):204-11. PubMed ID: 620482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of sulphamethoxazole in man: effects of urinary pH and urine flow on metabolism and renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole.
    Vree TB; Hekster YA; Baars AM; Damsma JE; van der Kleijn E
    Clin Pharmacokinet; 1978; 3(4):319-29. PubMed ID: 28128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of plasma protein binding on the metabolism and renal excretion of sulphadimethoxine and its metabolite N4-acetylsulphadimethoxine in pigs.
    Shimoda M; Vree TB; Beneken Kolmer EW; Arts TH
    Vet Q; 1990 Apr; 12(2):87-97. PubMed ID: 2363242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and mechanism of renal excretion of short acting sulphonamides and N4-acetylsulphonamide derivatives in man. Structural requirements of sulphonamides for active tubular secretion.
    Vree TB; Hekster YA; Damsma JE; Tijhuis M; Friesen WT
    Eur J Clin Pharmacol; 1981; 20(4):283-92. PubMed ID: 7308281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of levosimendan and its active metabolite OR-1896 in rapid and slow acetylators.
    Antila S; Pesonen U; Lehtonen L; Tapanainen P; Nikkanen H; Vaahtera K; Scheinin H
    Eur J Pharm Sci; 2004 Nov; 23(3):213-22. PubMed ID: 15489122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of sulfadimidine and its N4-acetyl metabolite in healthy and diseased rabbits infected with Pasteurella multocida.
    Yuan ZH; Fung KF
    J Vet Pharmacol Ther; 1990 Jun; 13(2):192-7. PubMed ID: 2384910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deacetylation as a determinant of sulphonamide pharmacokinetics in pigs.
    Shimoda M; Okamoto K; Sikazwe G; Fujii C; Son DS
    Vet Q; 1997 Nov; 19(4):186-91. PubMed ID: 9413118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal tubular excretion of the N4-acetyl metabolites of sulphasomidine and sulphadimethoxine in the dog.
    Boom SP; Wouterse AC; Vree TB; Van Ginneken CA; Russel FG
    J Pharm Pharmacol; 1993 Jul; 45(7):614-7. PubMed ID: 8105055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and renal clearance of sulfamethazine, sulfamerazine, and sulfadiazine and their N4-acetyl and hydroxy metabolites in horses.
    Nouws JF; Firth EC; Vree TB; Baakman M
    Am J Vet Res; 1987 Mar; 48(3):392-402. PubMed ID: 3565894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphic acetylation procainamide in man.
    Reidenberg MM; Drayer DE; Levy M; Warner H
    Clin Pharmacol Ther; 1975 Jun; 17(6):722-30. PubMed ID: 237647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma disposition and renal clearance of sulphadimidine and its metabolites in laying hens.
    Nouws JF; Geertsma MF; Grondel JL; Aerts MM; Vree TB; Kan CA
    Res Vet Sci; 1988 Mar; 44(2):202-7. PubMed ID: 3387673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of sulfamethazine disposition kinetics to acetylator phenotype in man. A preliminary study.
    Chapron CJ; Blum MR
    J Clin Pharmacol; 1976 Jul; 16(7):338-44. PubMed ID: 947966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylation of procainamide in man and its relationship to isonicotinic acid hydrazide acetylation phenotype.
    Gibson TP; Matusik J; Matusik E; Nelson HA; Wilkinson J; Briggs WA
    Clin Pharmacol Ther; 1975 Apr; 17(4):395-9. PubMed ID: 1122681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of acetylator phenotype on the disposition of aminoglutethimide.
    Adam AM; Rogers HJ; Amiel SA; Rubens RD
    Br J Clin Pharmacol; 1984 Oct; 18(4):495-505. PubMed ID: 6487491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma concentrations and pharmacokinetics of dihydralazine after single oral doses to human subjects.
    Waller AR; Chasseaud LF; Taylor T; Darragh A; O'Kelly DA
    Biopharm Drug Dispos; 1979; 1(2):59-64. PubMed ID: 552862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acecainide pharmacokinetics in normal subjects of known acetylator phenotype.
    Coyle JD; Boudoulas H; Lima JJ
    Biopharm Drug Dispos; 1991 Nov; 12(8):599-612. PubMed ID: 1724922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between the metabolism of procainamide and sulfamethazine.
    Giardina E-GV ; Stein RM; Bigger JT
    Circulation; 1977 Feb; 55(2):388-94. PubMed ID: 832354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age and dosage dependency in the plasma disposition and the renal clearance of sulfamethazine and its N4-acetyl and hydroxy metabolites in calves and cows.
    Nouws JF; Vree TB; Baakman M; Driessens F; Breukink HJ; Mevius D
    Am J Vet Res; 1986 Mar; 47(3):642-9. PubMed ID: 3963566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-acetylation and oxidative capacity in aged volunteers determined with sulfamethazine and antipyrine.
    Siegmund W; Franke G; Wulkow R; Hanke W; Thonack R
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):469-73. PubMed ID: 1813431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man.
    Vree TB; O'Reilly WJ; Hekster YA; Damsma JE; van der Kleijn E
    Clin Pharmacokinet; 1980; 5(3):274-94. PubMed ID: 7389236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.